Correction: Placental expanded mesenchymal-like cells (PLX-R18) for poor graft function after hematopoietic cell transplantation: A phase I study

Affiliations

• ¹ Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, USA. [email protected].
• ² Case Western Reserve University, Cleveland, OH, USA.
• ³ University Hospitals Seidman Cancer Center, Cleveland, OH, USA.
• ⁴ Apheresis and Marrow Processing Laboratories, Baylor University Medical Center, Dallas, TX, USA.
• ⁵ Division of Hematology, Mayo Clinic, Rochester, MN, USA.
• ⁶ Stem Cell Transplantation and Cellular Therapy Program, John Theurer Cancer Center, Hackensack, NJ, USA.
• ⁷ Hadassah University Medical Center, Jerusalem, Israel.
• ⁸ Memorial Sloan Kettering Cancer Center, New York, NY, USA.
• ⁹ Case Western Reserve University School of Medicine, Cleveland, OH, USA.
• ¹⁰ Department of Hematology, Shaare Zedek Medical Center, Jerusalem, Israel.
• ¹¹ The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel.
• ¹² Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel.
• ¹³ Pluri-Biotech Ltd., Haifa, Israel.